PAG
NVO

Private Advisor Group’s Novo Nordisk NVO Stock Holding History

Private Advisor Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,000
Closed -$23.7K – 2721
2025
Q3 		$23.7K Buy
+2,000
New +$117K ﹤0.01% 2490

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Private Advisor Group's NVO Position: Q1 2026 in Review

Private Advisor Group reduced its Novo Nordisk (NVO) stake by 20% in Q1 2026, selling an estimated $842K and leaving 70,000 shares worth $2.57M. The position accounts for 0.01% of the portfolio, ranked #937.

Private Advisor Group first reported a position in NVO in Q4 2013 and has held it in 50 quarters since. The position peaked at $13.4M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Private Advisor Group held 70,000 shares of Novo Nordisk worth $2.57M as of Q1 2026.
  • Private Advisor Group sold 17,770 Novo Nordisk shares in Q1 2026, an estimated $842K.
  • Novo Nordisk made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #937 holding.
  • Private Advisor Group first reported a position in Novo Nordisk in Q4 2013 and has held it in 50 quarters since.
  • Private Advisor Group's Novo Nordisk position peaked at $13.4M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.